Cyclopentenone prostaglandin, 15-deoxy-Δ12,14-PGJ2, Is metabolized by HepG2 cells via conjugation with glutathione

被引:28
|
作者
Brunoldi, Enrico A.
Zanoni, Giuseppe
Vidari, Giovanni
Sasi, Sournya
Freeman, Michael L.
Milne, Ginger L.
Morrow, Jason D.
机构
[1] Vanderbilt Univ, Sch Med, Dept Med & Pharmacol, Dept Radiat Oncol, Nashville, TN 37232 USA
[2] Univ Pavia, Dept Organ Chem, I-27100 Pavia, Italy
关键词
D O I
10.1021/tx700231a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
15-Deoxy-Delta(12,14)-prostaglandin J(2) (15-d-PGJ(2)) is a dehydration product of PGD(2). This compound possesses a highly reactive polyunsaturated carbonyl moiety that is a substrate for Michael addition with thiol-containing biomolecules such as glutathione and cysteine. residues on proteins. By reacting with glutathione and proteins, 15-d-PGJ(2) is believed to exert potent biological activity. Despite the large number of publications that have ascribed bioactivity to this molecule, it is not known to what extent 15-d-PGJ(2) is formed in vivo. Levels of free 15-d-PGJ(2) measured in human biological fluids such as urine are low, and the biological importance of this compound has thus been questioned. Because of its reactivity, we hypothesized that 15-d-PGJ(2) is present in vivo primarily as a Michael conjugate. Therefore, we undertook a detailed study of the metabolism of this compound in HepG2 cells that are known to metabolize other cyclopentenone eicosanoids. We report that HepG2 cells primarily convert 15-d-PGJ(2) to a glutathione conjugate in which the carbonyl at C-11 is reduced to a hydroxyl. Subsequently, the glutathione portion of the molecule is hydrolyzed with loss of glutamic acid and glycine resulting in a cysteine conjugate. These findings confirm a general route for the metabolism of cyclopentenone eicosanoids in HepG2 cells and may pave the way for new insights regarding the formation of 15-d-PGJ(2) in vivo.
引用
收藏
页码:1528 / 1535
页数:8
相关论文
共 50 条
  • [21] Measurement of 15-deoxy-Δ-12,14-PGJ2 in human urine by LC-electrospray ionization-MS
    Bell-Parikh, LC
    Zhou, H
    Lawson, JA
    Fitzgerald, GA
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) : A24 - A24
  • [22] 15-deoxy-Δ12,14-PGJ2 induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats
    Kawahito, Y
    Kondo, M
    Tsubouchi, Y
    Hashiramoto, A
    Bishop-Bailey, D
    Inoue, K
    Kohno, M
    Yamada, R
    Hla, T
    Sano, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (02): : 189 - 197
  • [23] Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 in human mesangial cells
    Zhang, XL
    Lu, L
    Dixon, C
    Wilmer, W
    Song, HJ
    Chen, XL
    Rovin, BH
    [J]. KIDNEY INTERNATIONAL, 2004, 65 (03) : 798 - 810
  • [24] S-aureus-dependent microglial activation is selectively attenuated by the cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 (15d-PGJ2)
    Kielian, T
    McMahon, M
    Bearden, ED
    Baldwin, AC
    Drew, PD
    Esen, N
    [J]. JOURNAL OF NEUROCHEMISTRY, 2004, 90 (05) : 1163 - 1172
  • [25] 15-Deoxy-Δ12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes
    Hyo Jin Kim
    Young Hee Rho
    Seong Jai Choi
    Young Ho Lee
    Hyeon Joo Cheon
    Jun Won Um
    Jeongwon Sohn
    Gwan Gyu Song
    Jong Dae Ji
    [J]. Experimental & Molecular Medicine, 2005, 37 : 179 - 185
  • [26] 15-deoxy-Δ12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes
    Kim, HJ
    Rho, YH
    Choi, SJ
    Lee, YH
    Cheo, HJ
    Um, JW
    Sohn, J
    Song, GG
    Ji, JD
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2005, 37 (03): : 179 - 185
  • [27] Rosiglitazone alleviates intrahepatic cholestasis induced by α-naphthylisothiocyanate in mice: The role of circulating 15-deoxy-Δ12,14-PGJ2 and Nogo
    Zhang, Shuang
    Yu, Miao
    Guo, Fangling
    Yang, Xiaoxiao
    Chen, Yuanli
    Ma, Chuanrui
    Li, Qi
    Wei, Zhuo
    Li, Xiaoju
    Wang, Hua
    Hu, Huaqing
    Zhang, Yujue
    Kong, Derun
    Miao, Qing Robert
    Hu, Wenquan
    Hajjar, David P.
    Zhu, Yan
    Han, Jihong
    Duan, Yajun
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (05) : 1041 - 1060
  • [28] Response to letter by Tsikas et al. 15-deoxy-Δ12,14-PGJ2: An interesting but unapproachable pharmacological target?
    Tsikas, Dimitrios
    Niemann, Jonas
    Beckmann, Bibiana
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (01) : 307 - 309
  • [29] The PPARγ ligand, 15-deoxy-Δ12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells
    Okano, H
    Shiraki, K
    Inoue, H
    Kawakita, T
    Deguchi, M
    Sugimoto, K
    Sakai, T
    Murata, K
    Nakano, T
    Enjoji, M
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (06) : 867 - 870
  • [30] The cyclopentenone prostaglandin 15-deoxy-Δ12,14-prostaglandin J2 ameliorates ischemic acute renal failure
    Chatterjee, PK
    Patel, NSA
    Cuzzocrea, S
    Brown, PAJ
    Stewart, KN
    Mota-Filipe, H
    Britti, D
    Eberhardt, W
    Pfeilschifter, J
    Thiemermann, C
    [J]. CARDIOVASCULAR RESEARCH, 2004, 61 (03) : 630 - 643